[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337957-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337957-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-journal-of-clinical-investigation-interruption-of-klf5-acetylation-promotes-pten-deficient-prostate-cancer-progression-by-reprogramming-cancer-associated-fibroblasts","The Journal of Clinical Investigation - Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts","","PTEN deficiency is common in human prostate cancer and contributes to high-grade disease with long latency, yet the mechanisms by which it remodels tumor microenvironment constraints remain unclear. The study shows PTEN loss induces acetylation of the transcription factor KLF5 and that interrupting KLF5 acetylation reshapes cancer-cell/CAF crosstalk. Deacetylated KLF5 triggers TNF-α release, stimulating inflammatory CAFs to produce FGF9 and activate FGFR1 signaling, enhancing tumor growth. CX3CR1 inhibition blocks FGF9-driven FGFR1 activation and sensitizes PTEN-deficient prostate cancer to capivasertib, supporting combined AKT and CX3CR1-targeted therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-journal-of-clinical-investigation-interruption-of-klf5-acetylation-promotes-pten-deficient-prostate-cancer-progression-by-reprogramming-cancer-associated-fibroblasts/337957/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-journal-of-clinical-investigation-interruption-of-klf5-acetylation-promotes-pten-deficient-prostate-cancer-progression-by-reprogramming-cancer-associated-fibroblasts/337957.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does PTEN deficiency play in prostate cancer in this study?","Question",{"text":63,"@type":64},"PTEN inactivation is shown to be prevalent in prostate cancer and is associated with progression barriers that require additional molecular and cellular responses. The work focuses on how PTEN-deficient cancers influence the tumor microenvironment to promote growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does KLF5 acetylation affect interactions between cancer cells and cancer-associated fibroblasts (CAFs)?",{"text":68,"@type":64},"PTEN deficiency induces KLF5 acetylation, and interrupting KLF5 acetylation coordinates signaling between cancer cells and CAFs. This enhanced crosstalk increases FGF receptor 1 (FGFR1) signaling to promote tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"How do CX3CR1 inhibition and capivasertib fit into the proposed therapeutic strategy?",{"text":72,"@type":64},"Deacetylated KLF5 drives TNF-α production that stimulates inflammatory CAFs to release FGF9. Inhibiting CX3CR1 blocks the resulting FGFR1 activation and sensitizes PTEN-deficient prostate cancer to the AKT inhibitor capivasertib.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337957,1790168091,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nInterruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts  \nBaotong Zhang,1,2,3 Mingcheng Liu,1 Fengyi Mai,1 Xiawei Li,1,4 Wenzhou Wang,1 Qingqing Huang,1 Xiancai Du,1 Weijian Ding,1 Yixiang Li,2,3 Benjamin G. Barwick,2,3 Jianping Jenny Ni,2,3 Adeboye O. Osunkoya,3,5 Yuanli Chen,6 Wei Zhou,2,3 Siyuan Xia,1,2,3 and Jin-Tang Dong1,2,3  \n1Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China. 2Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA. 3Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. 4Inner Mongolia Institute of Quality and Standardization, Inner Mongolia Administration for Market Regulation, Hohhot, China. 5Departments of Pathology and Urology, Emory University School of Medicine, Atlanta, Georgia, USA. 6Key Laboratory of Major Metabolic Diseases and Nutritional Regulation of Anhui Department of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, China.  \nInactivation of phosphatase and tensin homolog (PTEN) is prevalent in human prostate cancer and causes high-grade adenocarcinoma with a long latency. Cancer-associated fibroblasts (CAFs) play a pivotal role in tumor progression, but it remains elusive whether and how PTEN-deficient prostate cancers reprogram CAFs to overcome the barriers for tumor progression. Here, we report that PTEN deficiency induced Krüppel-like factor 5 (KLF5) acetylation and that interruption of KLF5 acetylation orchestrated intricate interactions between cancer cells and CAFs that enhance FGF receptor 1 (FGFR1) signaling and promote tumor growth. Deacetylated KLF5 promoted tumor cells to secrete TNF-α, which stimulated inflammatory CAFs to release FGF9. CX3CR1 inhibition blocked FGFR1 activation triggered by FGF9 and sensitized PTENdeficient prostate cancer to the AKT inhibitor capivasertib. This study reveals the role of KLF5 acetylation in reprogramming CAFs and provides a rationale for combined therapies using inhibitors of AKT and CX3CR1 .  \nIntroduction  \nProstate cancer is the most common cancer and the second leading cause of cancer-related death in men in the United States (1). Most prostate cancers are localized and androgen dependent at diagnosis and can thus be effectively treated with chemical castration, surgery, and radiation (2). Approximately 12% of prostate cancers progress to metastatic castration-resistant prostate cancer (mCRPC) (3), which contributes to mortality. Genetic drivers of prostate cancer have been extensively studied and defined to categorize disease subtypes and develop subtype-specific therapeutic strategies. One of the most potent genetic drivers of prostate cancer is phosphatase and tensin homolog (PTEN), a tumor suppressor gene that is mutated in approximately 20% of primary prostate cancers and in up to 50% of patients with mCRPC (4, 5).  \nPTEN inactivation results in prostate intraepithelial neoplasia (PIN) by activating PI3K/AKT signaling in genetically engineered mouse models, in which prostate cancer has a long latency to progressto high-grade adenocarcinoma, with metastasis occurring rarely  \nAuthorship note: BZ, ML, and FM are co–first authors and contributed equally to this work.  \nConflict of interest: The authors have declared that no conflict of interest exists. Copyright: © 2024, Zhang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: September 19, 2023; Accepted: May 21, 2024; Published: May 23, 2024.  \nReference information: J Clin Invest. 2024;134(14):e175949 .  \n[https://doi.org/10.1172/JCI175949](https://doi.org/10.1172/JCI175949) .  \n(6–8). The limited tumor progression induced by PTEN deficiency suggests that additio","cbCain5cd0GVM0GP","https://ap.wps.com/l/cbCain5cd0GVM0GP","pdf",22968676,17,"English","# Introduction\n## PTEN alterations and prostate cancer progression\n## Tumor microenvironment and second-hit mechanisms\n## TGF-β signaling in PTEN-deficient tumors\n# Results\n## PTEN loss induces KLF5 acetylation","[{\"question\":\"What role does PTEN deficiency play in prostate cancer in this study?\",\"answer\":\"PTEN inactivation is shown to be prevalent in prostate cancer and is associated with progression barriers that require additional molecular and cellular responses. The work focuses on how PTEN-deficient cancers influence the tumor microenvironment to promote growth.\"},{\"question\":\"How does KLF5 acetylation affect interactions between cancer cells and cancer-associated fibroblasts (CAFs)?\",\"answer\":\"PTEN deficiency induces KLF5 acetylation, and interrupting KLF5 acetylation coordinates signaling between cancer cells and CAFs. This enhanced crosstalk increases FGF receptor 1 (FGFR1) signaling to promote tumor growth.\"},{\"question\":\"How do CX3CR1 inhibition and capivasertib fit into the proposed therapeutic strategy?\",\"answer\":\"Deacetylated KLF5 drives TNF-α production that stimulates inflammatory CAFs to release FGF9. Inhibiting CX3CR1 blocks the resulting FGFR1 activation and sensitizes PTEN-deficient prostate cancer to the AKT inhibitor capivasertib.\"}]","The Journal of Clinical Investigation - Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts | PDF",1790021347,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b54bbee91b19ab2e2cc25bec7f63f094.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cea9d0cbbe2325311c9442473a033ad3.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd02923851efef5208826b8f375e4e6b.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e30c9d8f550e5ca2213e23867d83f3f.webp",980,1311]